Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Systematic Review: Adverse Events of Fecal Microbiota Transplantation.

Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, Yan F, Cao H, Wang B.

PLoS One. 2016 Aug 16;11(8):e0161174. doi: 10.1371/journal.pone.0161174. eCollection 2016.

2.

Controlling the Microbiome: Microhabitat Adjustments for Successful Biocontrol Strategies in Soil and Human Gut.

Adam E, Groenenboom AE, Kurm V, Rajewska M, Schmidt R, Tyc O, Weidner S, Berg G, de Boer W, Falcão Salles J.

Front Microbiol. 2016 Jul 13;7:1079. doi: 10.3389/fmicb.2016.01079. eCollection 2016. No abstract available.

3.

Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond.

Borody TJ, Peattie D, Mitchell SW.

Antibiotics (Basel). 2015 Jul 6;4(3):254-66. doi: 10.3390/antibiotics4030254. Review.

4.

Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.

Kumar R, Maynard CL, Eipers P, Goldsmith KT, Ptacek T, Grubbs JA, Dixon P, Howard D, Crossman DK, Crowley MR, Benjamin WH Jr, Lefkowitz EJ, Weaver CT, Rodriguez JM, Morrow CD.

BMC Microbiol. 2016 Jan 13;16:5. doi: 10.1186/s12866-015-0622-2.

5.

The effects of spatial structure, frequency dependence and resistance evolution on the dynamics of toxin-mediated microbial invasions.

Libberton B, Horsburgh MJ, Brockhurst MA.

Evol Appl. 2015 Aug;8(7):738-50. doi: 10.1111/eva.12284. Epub 2015 Jul 16.

6.

Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?

Bringiotti R, Ierardi E, Lovero R, Losurdo G, Di Leo A, Principi M.

World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):550-9. doi: 10.4291/wjgp.v5.i4.550. Review.

7.

The murine appendiceal microbiome is altered in spontaneous colitis and its pathological progression.

Alkadhi S, Kunde D, Cheluvappa R, Randall-Demllo S, Eri R.

Gut Pathog. 2014 Jun 21;6:25. doi: 10.1186/1757-4749-6-25. eCollection 2014.

8.

Obesity as a consequence of gut bacteria and diet interactions.

Kotzampassi K, Giamarellos-Bourboulis EJ, Stavrou G.

ISRN Obes. 2014 Mar 6;2014:651895. doi: 10.1155/2014/651895. eCollection 2014. Review. Retraction in: International Scholarly Research Notices. Int Sch Res Notices. 2015;2015:786924.

9.

Exploring the influence of the gut microbiota and probiotics on health: a symposium report.

Thomas LV, Ockhuizen T, Suzuki K.

Br J Nutr. 2014 Jul;112 Suppl 1:S1-18. doi: 10.1017/S0007114514001275.

10.

Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation.

Shankar V, Hamilton MJ, Khoruts A, Kilburn A, Unno T, Paliy O, Sadowsky MJ.

Microbiome. 2014 Apr 21;2:13. doi: 10.1186/2049-2618-2-13. eCollection 2014.

11.

Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection.

Fuentes S, van Nood E, Tims S, Heikamp-de Jong I, ter Braak CJ, Keller JJ, Zoetendal EG, de Vos WM.

ISME J. 2014 Aug;8(8):1621-33. doi: 10.1038/ismej.2014.13. Epub 2014 Feb 27.

12.

Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome.

Thompson A, Meah D, Ahmed N, Conniff-Jenkins R, Chileshe E, Phillips CO, Claypole TC, Forman DW, Row PE.

BMC Complement Altern Med. 2013 Nov 28;13:338. doi: 10.1186/1472-6882-13-338.

13.

Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.

Tsutsumi LS, Owusu YB, Hurdle JG, Sun D.

Curr Top Med Chem. 2014;14(1):152-75. Review.

14.

Antimicrobial peptides and gut microbiota in homeostasis and pathology.

Ostaff MJ, Stange EF, Wehkamp J.

EMBO Mol Med. 2013 Oct;5(10):1465-83. doi: 10.1002/emmm.201201773. Epub 2013 Aug 23. Review.

15.

Gut microbiota in inflammatory bowel disease.

Shim JO.

Pediatr Gastroenterol Hepatol Nutr. 2013 Mar;16(1):17-21. doi: 10.5223/pghn.2013.16.1.17. Epub 2013 Mar 31. Review.

16.

Fecal transplantation for the treatment of recurrent clostridium difficile infection.

Karadsheh Z, Sule S.

N Am J Med Sci. 2013 Jun;5(6):339-43. doi: 10.4103/1947-2714.114163.

17.

From molecules to dynamic biological communities.

McDonald D, Vázquez-Baeza Y, Walters WA, Caporaso JG, Knight R.

Biol Philos. 2013 Mar;28(2):241-259. Epub 2013 Feb 5.

18.

Fecal transplant in refractory Clostridium difficile colitis.

Kleger A, Schnell J, Essig A, Wagner M, Bommer M, Seufferlein T, Härter G.

Dtsch Arztebl Int. 2013 Feb;110(7):108-15. doi: 10.3238/arztebl.2013.0108. Epub 2013 Feb 15.

19.

Implications of the human microbiome project for epidemiology.

Foxman B, Rosenthal M.

Am J Epidemiol. 2013 Feb 1;177(3):197-201. doi: 10.1093/aje/kws449. Epub 2013 Jan 7.

20.

Fecal microbiota transplantation in relapsing Clostridium difficile infection.

Rohlke F, Stollman N.

Therap Adv Gastroenterol. 2012 Nov;5(6):403-20. doi: 10.1177/1756283X12453637.

Items per page

Supplemental Content

Write to the Help Desk